Last reviewed · How we verify
Methotrexate 10 mg
At a glance
| Generic name | Methotrexate 10 mg |
|---|---|
| Sponsor | King Edward Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases (PHASE1, PHASE2)
- Preventing Structural Damage in Early Psoriatic Arthritis (PHASE4)
- CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL (PHASE3)
- Combined Immunosuppression for Pediatric Crohn's Disease (PHASE4)
- Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma (PHASE2)
- LBL-2016 for Children or Adolescents in China (PHASE3)
- Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis (PHASE2)
- Methotrexate Versus Apremilast for Pruritus in Psoriasis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |